Differential protection by rat UDP-glucuronosyltransferase 1A7 against benzo[a]pyrene-3,6-quinone-versus benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cells

Toxicology and Applied Pharmacology

Volumn 162, Issue 1, 2000, Pages 34-43

  Grove, Andrew D ^a   Llewellyn, G Craig ^a   Kessler, Fay K ^a   White Jr , Kimber L ^a   Crespi, Charles L ^b   Ritter, Joseph K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Gentest Corporation   (United States)

Author keywords

Cytoprotection; Glucuronidation; Lymphoblastoid cells; NAD(P)H quinone oxidoreductase; Phase 2 detoxification enzymes; Polyaromatic hydrocarbons; UDP glucuronosyltransferase

Indexed keywords

BENZO[A]PYRENE; GLUCURONOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ANALYSIS; FLOW CYTOMETRY; GLUCURONIDATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL;

EID: 0033972277     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8815     Document Type: Article

References (34)

1. Bevan D. R., Sadler V. M. Quinol diglucuronides are predominant conjugated metabolites found in bile of rats following intratracheal instillation of benzo(a)pyrene. Carcinogenesis. 13:1992;403-407.
2. Bock K.W. Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 26:1991;129-150.
3. Bock K. W., Gschaidmeier H., Seidel A., Baird S., Burchell B. Mono- and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A6). Mol. Pharmacol. 42:1992;613-618.
4. Bock K. W., Raschko F. T., Gschaidmeier H., Seidel A., Oesch F., Grove A. D., Ritter J.K. Mono- and diglucuronide formation from benzo(a)pyrene and chrysene diphenols by AHH-1 cell expressed UDP-glucuronosyltransferase UGT1A7. Biochem. Pharmacol. 57:1999;653-656.
5. Burke M. D., Vadi H., Jernstrom B., Orrenius S. Metabolism of benzo(a)pyrene with isolated hepatocytes and the formation and degradation of DNA-binding derivatives. J. Biol. Chem. 252:1977;6424-6431.
6. Capdevila J., Orrenius S. Metabolism of benzo(a)pyrene-3,6-quinone by isolated hepatocytes. FEBS Lett. 119:1980;33-37.
7. Conney A. H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res. 42:1982;4875-4917.
8. Crespi, C. L., Altman, J. D., and Marletta, M. A.1985. Xenobiotic metabolism and mutation in a human lymphoblastoid cell line. Chem.- Biol. Interact.53, 257-272.
9. Crespi C. L., Langenbach R., Penman B. W. Hum cell lines, derived from AHH-1 TK +/- human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology. 82:1993;89-104.
10. Davies R. L., Crespi C. L., Rudo K., Turner T. R., Langenbach R. Development of a human cell line by selection and drug-metabolizing gene transfection with increased capacity to activate promutagens. Carcinogenesis. 10:1989;885-891.
11. DeLuca J. G., Weinstein L., Thilly W. G. Ultraviolet light induced mutation of diploid human lymphoblasts. Mutat. Res. 107:1983;347-370.
12. Emi Y., Ikushiro S., Iyanagi T. Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex. J. Biochem. (Tokyo). 117:1995;392-399.
13. Grove A. D., Kessler F. K., Metz R. P., Ritter J. K. Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J. Biol. Chem. 272:1997;1621-1627.
14. Gschaidmeier H., Seidel H., Burchell B., Bock K. W. Formation of mono- and diglucuronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem. Pharmacol. 49:1995;1601-1606.
15. Hu Z., Wells P. G. Modulation of benzo(a)pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. Toxicol. Appl. Pharmacol. 127:1994;306-313.
16. IARC. (International Agency for Research on Cancer), 1983, Polynuclear Aromatic Compounds, Part 1: Chemical, Environmental, and Experimental Data. In, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, IARC, Lyon, France.
17. Kawabata T. T., White K. L. Jr. Benzo(a)pyrene metabolism by murine spleen microsomes. Cancer Res. 49:1989;5816-5822.
18. Lesko S. A., Trpis L., Zheng R. Somatic mutation, DNA damage, and cytotoxicity induced by benzo(a)pyrenedione/benzo(a)pyrenediol redox couples in cultured mammalian cells. Mutat. Res. 161:1986;173-180.
19. Lilienblum W., Bock-Hennig B. S., Bock K. W. Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide. Mol. Pharmacol. 27:1985;451-458.
20. Lind C. Formation of benzo(a)pyrene-3,6-quinol mono- and diglucuronides in rat liver microsomes. Arch. Biochem. Biophys. 240:1985;226-235.
21. Lorentzen R. J., Lesko S. A., McDonald K., Ts'o P. O. Toxicity of metabolic benzo(a)pyrenediones to cultured cells and the dependence upon molecular oxygen. Cancer Res. 39:1979;3194-3198.
22. Lorentzen R. J., Ts'o P. O. Benzo(a)pyrenedione/benzo(a)pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxygen. Biochemistry. 16:1977;1467-1473.
23. Mackenzie P. I., Rodbourn L., Iyanagi T. Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5′-diphosphate glucuronosyltransferase. Cancer Res. 53:1993;1529-1533.
24. Mojarrabi B., Mackenzie P. I. Characterization of two UDP-glucuronosyltransferases that are predominantly expressed in human colon. Biochem. Biophys. Res. Commun. 247:1998;704-709.
25. Monteith D. K., Michalopoulos G., Strom S. C. Conjugation of chemical carcinogens by primary cultures of human hepatocytes. Xenobiotica. 20:1990;753-763.
26. Morris S. M., McGarrity L. J., Domon O. E., Chen J. J., Hinson W. G., Bucci T. J., Warbritton A. R., Casciano D. A. The role of programmed cell death in the toxicity of the mutagens, ethyl methanesulfonate and N-ethyl-N′-nitrosourea, in AHH-1 human lymphoblastoid cells. Mutat. Res. 306:1994;19-34.
27. Munzel P. A., Bruck M., Bock K. W. Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase. Biochem. Pharmacol. 20:1994;1445-1448.
28. Report on Carcinogens. 1998;National Institute of Environmental Health Sciences, Research Triangle Park.
29. Osborne M. R., Crosby N. T. Benzopyrenes. 1987;Cambridge Univ. Press, New York.
30. Owens I. S., Koteen G. M., Legraverend C. Mutagenesis of certain benzo(a)pyrene phenols in vitro following further metabolism by mouse liver. Biochem. Pharmacol. 28:1979;1615-1622.
31. Ritter J. K., Kessler F. K., Thompson M. T., Grove A. D., Auyeung D. J., Fisher R. A. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured human hepatocytes: evidence for both genetic and environmental influences. Hepatology. 30:1999;476-484.
32. Thakker D. R., Yagi H., Levin W., Wood A. W., Conney A. H., Jerina D. M. Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. Anders M. W. Bioactivation of Foreign Compounds. 1985;178-242 Academic Press, New York.
33. Vienneau D. S., DeBoni U., Wells P. G. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. Cancer Res. 55:1995;1045-1051.
34. Wislocki P. G., Wood A. W., Chang R. L., Levin W., Yagi H., Hernandez O., Dansette P. M., Jerina D. M., Conney A. H. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. Cancer Res. 36:1976;3350-3357.